Karista — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Waivwaiv.comMar 2026 · $33M
Waiv provides AI-powered digital pathology services for biopharma companies, offering co-development partnerships that span AI biomarker discovery, algorithm validation, SaMD development, regulatory strategy (CE-IVD/FDA), and companion diagnostic commercialization.
AI & Machine LearningBiotechDigital Health
Co-investorsSerenaSistaAlpha Intelligence CapitalOTB VenturesSerena Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



